Cardiac Biotech Solutions

Cardiac Biotech Solutions, Inc. engages in the provision of products and services in the ambulatory non-invasive cardiac monitoring space. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2001-09-28. The Company, through its international subsidiaries, provides products and services in the ambulatory non-invasive cardiac monitoring space. Its electrocardiogram (EKG) devices, interactive cloud-based acquisition software, and smartphone apps for both iPhone operating system (iOS) and Android platforms, enhance patient compliance and provide improved compliance for patients at risk of abnormal heart rhythms, as well as more accurate information for physicians. Its advanced technology is designed to improve patient outcomes and streamline cardiac monitoring for healthcare providers. Its MyCardia AT cardiac event monitor helps physicians detect, identify, and diagnose potential cardiac arrhythmias in patients with intermittent transient symptoms closer to the time that they occur up to a 30-day monitoring period.